Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

Amyloid-β metabolism in N… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Amyloid-β metabolism in Niemann-Pick C disease models and patients.

Artikel i vetenskaplig tidskrift
Författare Niklas Mattsson
Maria Olsson
Mikael K Gustavsson
Marko Kosicek
Martina Malnar
Jan-Eric Månsson
Maria K. Blomqvist
Johan Gobom
Ulf Andreasson
Gunnar Brinkmalm
Charles Vite
Silva Hecimovic
Caroline Hastings
Kaj Blennow
Henrik Zetterberg
Erik Portelius
Publicerad i Metabolic brain disease
Volym 27
Nummer/häfte 4
Sidor 573-85
ISSN 1573-7365
Publiceringsår 2012
Publicerad vid Institutionen för neurovetenskap och fysiologi
Institutionen för biomedicin, avdelningen för klinisk kemi och transfusionsmedicin
Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi
Institutionen för biologi och miljövetenskap
Sidor 573-85
Språk en
Länkar dx.doi.org/10.1007/s11011-012-9332-...
Ämnesord Amyloid beta-Peptides, analysis, cerebrospinal fluid, metabolism, Amyloid beta-Protein Precursor, metabolism, Animals, Carrier Proteins, genetics, Cats, Cell Line, Tumor, Child, Child, Preschool, Chromatography, High Pressure Liquid, Female, Humans, Immunoprecipitation, Infant, Male, Membrane Glycoproteins, genetics, Mutation, Missense, genetics, Niemann-Pick Disease, Type C, genetics, metabolism, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization, Tandem Mass Spectrometry, beta-Cyclodextrins, therapeutic use, tau Proteins, metabolism
Ämneskategorier Neurokemi

Sammanfattning

Niemann-Pick type C (NPC) is a progressive neurodegenerative lysosomal disease with altered cellular lipid trafficking. The metabolism of amyloid-β (Aβ) - previously mainly studied in Alzheimer's disease - has been suggested to be altered in NPC. Here we aimed to perform a detailed characterization of metabolic products from the amyloid precursor protein (APP) in NPC models and patients. We used multiple analytical technologies, including immunoassays and immunoprecipitation followed by mass spectrometry (IP-MS) to characterize Aβ peptides and soluble APP fragments (sAPP-α/β) in cell media from pharmacologically (U18666A) and genetically (NPC1 ( -/- ) ) induced NPC cell models, and cerebrospinal fluid (CSF) from NPC cats and human patients. The pattern of Aβ peptides and sAPP-α/β fragments in cell media was differently affected by NPC-phenotype induced by U18666A treatment and by NPC1 ( -/- ) genotype. U18666A treatment increased the secreted media levels of sAPP-α, AβX-40 and AβX-42 and reduced the levels of sAPP-β, Aβ1-40 and Aβ1-42, while IP-MS showed increased relative levels of Aβ5-38 and Aβ5-40 in response to treatment. NPC1 ( -/- ) cells had reduced media levels of sAPP-α and Aβ1-16, and increased levels of sAPP-β. NPC cats had altered CSF distribution of Aβ peptides compared with normal cats. Cats treated with the potential disease-modifying compound 2-hydroxypropyl-β-cyclodextrin had increased relative levels of short Aβ peptides including Aβ1-16 compared with untreated cats. NPC patients receiving β-cyclodextrin had reduced levels over time of CSF Aβ1-42, AβX-38, AβX-40, AβX-42 and sAPP-β, as well as reduced levels of the axonal damage markers tau and phosphorylated tau. We conclude that NPC models have altered Aβ metabolism, but with differences across experimental systems, suggesting that NPC1-loss of function, such as in NPC1 ( -/- ) cells, or NPC1-dysfunction, seen in NPC patients and cats as well as in U18666A-treated cells, may cause subtle but different effects on APP degradation pathways. The preliminary findings from NPC cats suggest that treatment with cyclodextrin may have an impact on APP processing pathways. CSF Aβ, sAPP and tau biomarkers were dynamically altered over time in human NPC patients.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?